carbamazepine has been researched along with clomipramine in 37 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (18.92) | 18.7374 |
1990's | 8 (21.62) | 18.2507 |
2000's | 10 (27.03) | 29.6817 |
2010's | 12 (32.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
Chang, TK; Ensom, MH; Kiang, TK | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chang, G; Di, L; Huang, Y; Lin, Z; Liston, TE; Scott, DO; Troutman, MD; Umland, JP | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Artursson, P; Mateus, A; Matsson, P | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Gerson, GR; Jones, RB; Luscombe, DK | 1 |
Fletcher, HP; Schnell, RC; Wannarka, GL | 1 |
Greengrass, PM; Imhof, PR; Maitre, L; Waldmeier, PC | 1 |
De la Fuente, JM; Mendlewicz, J | 1 |
Alarcon, RD; Johnson, BR; Lucas, JP | 1 |
Bojs, G; Ljunggren, B | 1 |
Nightingale, SL | 1 |
Dengler, W; Gerhardt, P; Hartung, HP; Wurthmann, C | 1 |
Fischer, W; Heydenreich, F; Rabending, G; Streubel, FR | 1 |
Borg, V | 1 |
Ebinger, G; Michotte, Y; Sarre, S; Van Belle, K | 1 |
Ishikura, T; Jibiki, I; Kubota, T | 1 |
Brissot, R; Gallien, P; Lebot, MP; Nicolas, B; Robineau, S | 1 |
Elia, J; Rowan, A; Weller, EB; Weller, RA | 1 |
Hoshino, R; Iwata, Y; Iyo, M; Kotani, Y; Mori, N; Takei, N | 1 |
van Duijn, H; Wouda, EJ | 1 |
He, L; Wu, B; Zhou, M | 1 |
Chen, N; He, L; Yang, M; Zakrzewska, JM; Zhou, M | 1 |
Chen, N; He, L; Yang, M; Zakrzewska, JM; Zhang, J; Zhou, M | 1 |
7 review(s) available for carbamazepine and clomipramine
Article | Year |
---|---|
UDP-glucuronosyltransferases and clinical drug-drug interactions.
Topics: Clinical Trials as Topic; Drug Interactions; Enzyme Activation; Enzyme Induction; Glucuronides; Glucuronosyltransferase; Humans; Pharmaceutical Preparations; Pharmacogenetics; Polymorphism, Genetic | 2005 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Aggressive behavior in patients with attention-deficit/hyperactivity disorder, conduct disorder, and pervasive developmental disorders.
Topics: Adolescent; Aggression; Attention Deficit Disorder with Hyperactivity; Carbamazepine; Child; Child Development Disorders, Pervasive; Clinical Trials as Topic; Clomipramine; Clonidine; Conduct Disorder; Humans; Lithium; Methylphenidate; Psychotropic Drugs; Treatment Outcome | 1999 |
[Unwanted napping].
Topics: Adult; Anticonvulsants; Antidepressive Agents, Tricyclic; Carbamazepine; Clomipramine; Diagnosis, Differential; Disorders of Excessive Somnolence; Female; HLA-DR2 Antigen; Humans; Male; Middle Aged; Narcolepsy; Nocturnal Myoclonus Syndrome; Polysomnography; Positive-Pressure Respiration; Sleep Apnea, Obstructive | 2001 |
Non-antiepileptic drugs for trigeminal neuralgia.
Topics: Amitriptyline; Baclofen; Carbamazepine; Clomipramine; Clonidine; Humans; Pimozide; Propoxycaine; Randomized Controlled Trials as Topic; Tocainide; Trigeminal Neuralgia | 2006 |
Non-antiepileptic drugs for trigeminal neuralgia.
Topics: Amitriptyline; Analgesics; Baclofen; Carbamazepine; Clomipramine; Clonidine; Humans; Pimozide; Propoxycaine; Randomized Controlled Trials as Topic; Tocainide; Trigeminal Neuralgia | 2011 |
Non-antiepileptic drugs for trigeminal neuralgia.
Topics: Amitriptyline; Analgesics; Anticonvulsants; Baclofen; Carbamazepine; Clomipramine; Clonidine; Humans; Pimozide; Propoxycaine; Randomized Controlled Trials as Topic; Tocainide; Trigeminal Neuralgia | 2013 |
3 trial(s) available for carbamazepine and clomipramine
Article | Year |
---|---|
Studies on the concomitant use of carbamazepine and clomipramine for the relief of post-herpetic neuralgia.
Topics: Age Factors; Aged; Carbamazepine; Clomipramine; Dibenzazepines; Drug Combinations; Electric Stimulation Therapy; Female; Herpes Zoster; Humans; Male; Middle Aged; Neuralgia | 1977 |
[Quantitative EEG analysis of a single dose of psychotropic drugs in healthy probands].
Topics: Adult; Arousal; Brain; Carbamazepine; Clomipramine; Desipramine; Diazepam; Electroencephalography; Evoked Potentials; Female; Haloperidol; Humans; Imipramine; Male; Psychotropic Drugs | 1986 |
[Clinical trial of Tegretol and Anafranil/Sinequan in alcohol abstinence symptoms].
Topics: Alcoholism; Carbamazepine; Clinical Trials as Topic; Clomipramine; Depression; Double-Blind Method; Doxepin; Drug Administration Schedule; Drug Therapy, Combination; Humans; Male; Substance Withdrawal Syndrome | 1980 |
27 other study(ies) available for carbamazepine and clomipramine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Species independence in brain tissue binding using brain homogenates.
Topics: Animals; Brain; Dogs; Guinea Pigs; Humans; Macaca fascicularis; Mice; Rats; Species Specificity | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
A high-throughput cell-based method to predict the unbound drug fraction in the brain.
Topics: Animals; Brain; Dialysis; HEK293 Cells; High-Throughput Screening Assays; Humans; Pharmaceutical Preparations; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2014 |
Variations of chlorpromazine-related isosteres on the glycemic response in mice.
Topics: Adrenalectomy; Animals; Blood Glucose; Carbamazepine; Chlorpromazine; Clomipramine; Cyproheptadine; Hyperglycemia; Imipramine; Insulin; Islets of Langerhans; Male; Mice; Promazine | 1979 |
Comparison of the effects of maprotiline (ludiomil) and clomipramine (anafranil) on serotonin uptake and tryptophan-binding in plasma.
Topics: Animals; Anthracenes; Aspirin; Blood Platelets; Brain; Carbamazepine; Clomipramine; Dibenzazepines; Humans; Male; Maprotiline; Norepinephrine; Rats; Sensory Receptor Cells; Serotonin; Tryptophan | 1976 |
Carbamazepine addition in tricyclic antidepressant-resistant unipolar depression.
Topics: Aged; Anxiety Disorders; Carbamazepine; Clomipramine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Personality Inventory; Recurrence | 1992 |
Paranoid and aggressive behavior in two obsessive-compulsive adolescents treated with clomipramine.
Topics: Adolescent; Aggression; Carbamazepine; Child; Clomipramine; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Paranoid Disorders | 1991 |
A case of photosensitivity and contact allergy to systemic tricyclic drugs, with unusual features.
Topics: Adult; Carbamazepine; Chemical and Drug Induced Liver Injury; Clomipramine; Cross Reactions; Dermatitis, Contact; Drug Eruptions; Humans; Male; Photosensitivity Disorders | 1991 |
From the Food and Drug Administration.
Topics: Apnea; Carbamazepine; Clomipramine; Food Labeling; Humans; Humidity; Monitoring, Physiologic; Obsessive-Compulsive Disorder; United States; United States Food and Drug Administration | 1990 |
[Kleine-Levin syndrome. The provocation of manic symptoms by an antidepressant and a therapeutic trial of carbamazepine].
Topics: Adolescent; Bipolar Disorder; Carbamazepine; Clomipramine; Disorders of Excessive Somnolence; Drug Evaluation; Feeding and Eating Disorders; Humans; Male; Psychopathology; Recurrence; Remission, Spontaneous; Sleep Wake Disorders; Syndrome | 1989 |
Brain, liver and blood distribution kinetics of carbamazepine and its metabolic interaction with clomipramine in rats: a quantitative microdialysis study.
Topics: Animals; Blood-Brain Barrier; Brain; Carbamazepine; Clomipramine; Drug Interactions; Extracellular Space; Liver; Male; Microdialysis; Rats; Rats, Wistar | 1995 |
Three cases of alopecia areata induced by zotepine.
Topics: Adult; Alopecia; Alopecia Areata; Antipsychotic Agents; Autoimmune Diseases; Carbamazepine; Clomipramine; Depressive Disorder; Diagnosis, Differential; Dibenzothiepins; Female; Haloperidol; Humans; Middle Aged; Schizophrenia | 1993 |
The reflex sympathetic dystrophy syndrome in patients who have had a spinal cord injury.
Topics: Adult; Analgesics, Non-Narcotic; Antidepressive Agents, Tricyclic; Arthrography; Calcitonin; Carbamazepine; Clomipramine; Humans; Middle Aged; Pain Measurement; Reflex Sympathetic Dystrophy; Risk Factors; Spinal Cord Injuries; Treatment Outcome | 1995 |
Carbamazepine augmentation of clomipramine in the treatment of refractory obsessive-compulsive disorder.
Topics: Adult; Anticonvulsants; Carbamazepine; Clomipramine; Drug Therapy, Combination; Female; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors | 2000 |